JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yates, P. A.
Right arrow Articles by Turker, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yates, P. A.
Right arrow Articles by Turker, M. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 51, 36357-36361, December 17, 1999


Tandem B1 Elements Located in a Mouse Methylation Center Provide a Target for de Novo DNA Methylation*

Phillip A. YatesDagger , Robert W. Burman§, Padmaja Mummaneni, Sandra KrusselDagger , and Mitchell S. TurkerDagger §||

From the Dagger  Center for Research on Occupational and Environmental Toxicology and § Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon 97201 and  Section on Neuroendocrinology, Laboratory of Developmental Neurobiology, 49/5A38, NICHD, National Institutes of Health, Bethesda, Maryland 20892

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A cis-acting methylation center that signals de novo DNA methylation is located upstream of the mouse Aprt gene. In the current study, two approaches were taken to determine if tandem B1 repetitive elements found at the 3' end of the methylation center contribute to the methylation signal. First, bisulfite genomic sequencing demonstrated that CpG sites within the B1 elements were methylated at relative levels of 43% in embryonal stem cells deficient for the maintenance DNA methyltransferase when compared with wild type embryonal stem cells. Second, the ability of the B1 elements to signal de novo methylation upon stable transfection into mouse embryonal carcinoma cells was examined. This approach demonstrated that the B1 elements were methylated de novo to a high level in the embryonal carcinoma cells and that the B1 elements acted synergistically. The results from these experiments provide strong evidence that the tandem B1 repetitive elements provide a significant fraction of the methylation center signal. By extension, they also support the hypothesis that one role for DNA methylation in mammals is to protect the genome from expression and transposition of parasitic elements.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Several lines of evidence support the hypothesis that a primary function of CpG methylation in mammals is to protect the genome from the expression and transposition of parasitic DNA elements (1, 2). Transposons represent ~35% of the human genome, yet they contain the majority of genomic 5-methylcytosine bases. Most transposons are retroposons that have integrated into multiple genomic locations via RNA intermediates. For example, the abundant human Alu elements and the homologous mouse B1 elements apparently arose from the reverse transcription and integration of 7SL RNA (3, 4). DNA methylation has been shown to repress the transcription of Alu sequences both in vitro and in vivo (5, 6). Similarly, DNA methylation apparently represses mouse IAP retroviral element transcription as DNA methyltransferase (Dnmt1)-deficient mouse embryos express dramatically increased IAP transcript levels when compared with wild type embryos (7). Moreover, retroviral long terminal repeats are both methylated and repressed following introduction into embryonal cell types (8).

One prediction of the protective hypothesis for DNA methylation is that retroposons should serve as substrates for de novo DNA methylation (9). We have described previously an 838-base pair methylation center located upstream of the mouse adenine phosphoribosyltransferase (Aprt) gene (see Fig. 1A) that signals de novo methylation upon transfection into mouse embryonal carcinoma (EC)1 cells (10). We report here that two tandem B1 elements are located at the 3' end of the methylation center. These elements are methylated at relatively high levels in embryonic cells with severe Dnmt1 deficiency. Such cells have little or no maintenance methylation activity but retain de novo methylation activity (11). In addition, the B1 elements became methylated de novo when transfected into mouse EC cells. Together, these results suggest that these B1 repetitive elements account for a significant portion of the Aprt methylation center signal.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture and Transfection-- The wild type and Dnmtc/c ES cells were grown in leukemia inhibitory factor-supplemented medium as described (11). The EC cells used were P19H22 and DelTG3. P19H22 contains a single allele of the Aprt gene derived from the C3H mouse strain (12, 13). DelTG3 lacks both Aprt alleles (10). Culture and electroporation of the EC cells were performed as described (14).

Bisulfite Sequencing-- For P19H22 DNA, bisulfite modification was carried out as described (15) with the following modifications. 2 µg of HpaI-digested genomic DNA (see Fig. 1A for location of HpaI sites) was denatured in 0.3 M NaOH at 75 °C for 5 min. The denatured DNA was mixed with 500 µl of 4.8 M sodium bisulfite and 28 µl of 10 mM hydroquinone, covered with mineral oil, and incubated at 55 °C for 4 h in the dark. DNA was desalted using a QIAquick PCR purification kit (Qiagen) according to the manufacturer's instructions. The samples were desulfonated in 0.3 M NaOH at 37 °C for 15 min and neutralized by the addition of 5 M sodium acetate. 1 µl of GenElute-LPA carrier (Supelco) was added, and the samples were precipitated by the addition of 2.5 volumes of 100% ethanol. The precipitated DNA was recovered by centrifugation, and the pellet was rinsed with 75% ethanol and air-dried. The pellet was resuspended in 25 µl of Tris-EDTA and stored at -20 °C before PCR.

For the wild type and Dnmtc/c ES cells, 2 µg of HpaI-digested DNA was modified in a solution of 5.36 M urea, 3.44 M sodium bisulfite, and 0.5 mM hydroquinone as described (16). The modified samples were desalted, desulfonated, precipitated, and stored as described above for P19H22 DNA.

Bisulfite-modified DNA was subjected to semi-nested PCR using primers specific for the modified DNA. The primers were designed to specifically amplify the modified sense strand. First, 1 µl of modified DNA was subjected to PCR using primers S1 (TTT GAA GGT TTA TGG GAG TTG) and AC (ATC TAA CAC ACA ATC TCC CAT C) (see Fig. 2A). The PCR conditions were as follows: 1 cycle of 95 °C for 9 min; 30 cycles of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 45 s; 1 cycle of 72 °C for 3 min. The resultant PCR products were diluted 100-fold, and 1 µl was subjected to 25 cycles of PCR under the same conditions using primers S2 (ATT TGT GTA GTA ATT GTA GAG TTA AGG TTG) (see Fig. 2A) and AC. Products from this semi-nested PCR were subcloned using a TOPO-TA cloning kit (Invitrogen) according to the manufacturer's instructions and sequenced. In all cases, clones derived from at least two independent PCR reactions were sequenced.

Construct Preparation-- Each construct was made by using PCR to amplify the desired fragment (see Fig. 1A) and blunt end-ligating the amplified fragment into the HL construct (see Figs. 1, B and C) (10). Artificial HpaII sites (H*) and site-directed mutations were introduced by placing these changes on the primers. The sequence for this region has the accession number l15342.

Southern Blot Procedures-- The methods used for Southern blot analysis of DNA preparations from transfectants are described elsewhere (14, 17).

Determination of Methylation Levels for HpaII Sites on Transfected Constructs-- Images of Southern blots were acquired with PhosphorImager SI (Molecular Dynamics), and the intensities of the individual hybridizations bands were determined with ImageQuant software (Molecular Dynamics). All Southern blot membranes were hybridized with random prime 32P-labeled fragments (Roche Molecular Biochemicals) generated from the N1 probe (see Fig. 1A). The 1.05 (1.2)- and 1.15 (1.3)-kilobase pair hybridization bands (see Fig. 1C) represent methylation of the H1 and H2 sites with or without concomitant methylation of the artificial H* site, respectively. The 0.65 (0.8)- and 0.75 (0.9)-kilobase pair hybridization bands represent methylation of the H1 site, again with or without methylation of the artificial H* site, respectively. Finally, the 0.4- and 0.5-kilobase pair hybridization bands were derived from unmethylated regions (see Fig. 1C). The signal intensity was determined for each hybridization band and then adjusted to reflect its relative theoretical degree of hybridization to the N1 probe. The percent methylation for a given HpaII site was determined by dividing the sum of the signal intensities for hybridization bands representing methylation at that site by the sum of the signal intensities from bands representing both methylation and the absence of methylation of that site.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Tandem B1 Elements Were Located at the 3' End of the Methylation Center-- The methylation center (Fig. 1A) is a cis-acting element involved in establishing the methylation pattern upstream of the mouse Aprt promoter (9, 10). Sequence analysis revealed the presence of tandem B1 repetitive elements at the 3' end of the methylation center (B1-5 and B1-6, Figs. 1A and 2A). These elements are located in a 3'-5' direction (i.e. tail to head) relative to the 5' end of the Aprt promoter. The sequences for the B1-5 and B1-6 elements are shown in Fig. 2B. Both B1-5 and B1-6 are similar to the consensus B1 element (18) (92 and 87%, respectively), except that B1-6 lacks the first 13 nucleotides at the 5' end of the consensus element. The B1-5 and B1-6 elements are 84% homologous with each other.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   A, map of Aprt upstream region. The small box upstream of the H3 site indicates the Aprt promoter region. The H0-H3 sites represent HpaII sites, and the levels of speckling represent the relative levels of methylation observed in the P19 EC cell line and in most adult mouse tissues. Based on Southern blot analysis, these levels are 100% for the H1 and H1a sites, 0% methylation for the H3 site, approximately 25% methylation for the H2 site, and 0-15% methylation for the H0 site (17, 19). The methylation center (MC), as defined elsewhere (10), is shown bracketed by the H1a and H1 sites. Two B1 elements (B1-5 and B1-6) are shown at the 3' end of the methylation center. The arrowhead represents the 5' end of the elements, and the 3' poly(A) tail is located at the base of the arrow. The N1 probe was used for the Southern blot analysis (Figs. 3-5). The B1 dimer fragment, 272-base pair fragment, and the B1-5 and B1-6 elements were cloned into the HpaI site of the HL construct (see text). Ps, PstI site; Hp, HpaI site. B, the HL construct was created by removing a 1.4-kilobase pair (kb) HpaI fragment (Fig. 1A) from the pSam6.3 construct as described elsewhere (10). The H0 and H2 sites on this construct did not become methylated when HL was transfected into mouse EC cells (10). C, a representative HLB1 construct is shown. The lines shown represent the molecular sizes of hybridization bands that are seen in with a Southern blot analysis for the transfected HLB1-5 (Fig. 5) and HLB1-6 (Fig. 3) constructs. The numbers shown in parentheses represent the corresponding molecular sizes for the HLB1-dimer construct (Fig. 3).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   A, CpG sites that flank and are located within the B1-5 and B1-6 repetitive elements (1-8). CpG site number 7 corresponds to the H1 site in Fig. 1A. The arrows labeled S1, S2, and AC are primers used for bisulfite sequencing (See "Experimental Procedures"). B, sequences of the B1-5, B1-6, and consensus (CONS.) (18) B1 elements. All CpG sites are underlined, and the H1 site at the 5' end of B1-5 is bold. C, results from bisulfite sequencing for CpG sites 1-8 for the wild type (WT) EC and ES cells and the Dnmtc/c ES cells. Each line represents an independent result; + indicates a methylated CpG site, and - indicates an unmethylated site. CpG sites 1-8 correspond with those shown in panel A of this figure. CpG site 2 is not present in the ES cells.

The B1 Elements Were Methylated in Dnmtc/c Embryonal Stem Cells-- Southern blot analysis demonstrated in previous studies that the HpaII site termed H1 (Fig. 1A) was completely methylated in EC cells and adult tissues (10, 19). To determine if methylation at the H1 site in EC cells is representative of methylation at nearby CpG sites, bisulfite genomic sequencing was used to examine methylation status for all CpG sites within the B1-5 (sites 4-7) and B1-6 elements (sites 2-3) and two flanking CpG sites (sites 1 and 8) (Fig. 2A). As shown in Fig. 2C, all CpG sites were methylated in 15 of 20 alleles analyzed from the P19H22 EC cells, and overall 148 out of a possible 160 CpG sites (93%) were methylated. These results confirm that methylation of the H1 site, as determined by Southern blot analysis, provides a good barometer for methylation of other CpG sites located in the B1 elements or just outside these elements. The H1 site was methylated in 17 of 20 sequenced clones (85%). Therefore, the results also suggest that a low level of unmethylated H1 sites is not detected by Southern analysis or, alternatively, that the bisulfite method slightly overestimates the number of unmethylated H1 sites.

Cells with knockout mutations for the Dnmt1 allele, which encodes the maintenance DNA methyltransferase in mouse cells, have markedly reduced levels of CpG methylation. This is particularly true for cells homozygous for the Dnmtc/c allele, which has a mutation eliminating catalytic activity (11). However, these cells still retain the capacity for de novo methylation (11) and, therefore, provide a good system in which to test for CpG sites that serve as substrates for de novo methylation. Methylation levels in ES cells wild type for Dnmt1 and homozygous for the Dnmtc/c allele were determined for seven of the eight CpG sites shown in Fig. 2A. Sequence analysis revealed a CG to TA transition that eliminated CpG site 2 in the ES cell lines, which are 129/Sv-derived. The overall level of methylation for the CpG sites within the wild type ES cells (62%) was lower than that for the EC cells (93%); only 2 out of 11 sequenced clones were methylated at all 7 CpG sites. The CpG sites within and flanking the B1 elements in the Dnmtc/c ES cells were methylated at unexpectedly high levels, with 19 out of 70 (27%) sites being methylated. This relative level of methylation was 43% that observed for the wild type ES cells. At least 1 CpG site within the B1 elements was methylated in 9 of the 10 clones sequenced, although no specific pattern could be discerned.

De Novo Methylation of the B1 Elements upon Stable Transfection into EC Cells-- The observation of a relatively high level of B1 element methylation in the Dnmtc/c cells suggested that the repetitive element region acts as a signal for de novo DNA methylation. To test this possibility directly, the B1-5 and B1-6 elements were inserted as a dimer (i.e. their normal genomic configuration) into the HL construct (Fig. 1B) to create the HLB1-dimer construct. The HL construct lacks the methylation center (Figs. 1, A and B), and as a result, it remains unmethylated when introduced stably into EC cells (10). Therefore, it provides a "null" cassette to test methylation potential for inserted fragments. An artificial HpaII site (H*) was added at the 5' end of the B1-dimer insert; its 3' end was the H1 site (Fig. 1A).

Southern blot analysis demonstrated that the HLB1-dimer became methylated to a high level in stably transfected EC clones (Fig. 3, Table I). The H1 site was methylated at an average level of 88% (Table I), and the H* site, at a minimal average level of 59% (our assay does not detect methylation at the H* site in the absence of methylation at the H1 site). The distal H2 site, whose methylation is dependent upon the presence of the methylation center or fragments that include it (10), was methylated at an average level of 27%. To confirm that the observed methylation was a function of the inserted B1 elements, a contiguous 272-base pair fragment that contained the H1 site at its 5' end and an HpaI site at its 3' end (Fig. 1A) was inserted into HL to create HL272. Methylation of the H1 site on the HL272 construct was observed in only 2 of 8 transfectants with an average level of 6.5% (Table I, Fig. 4). Methylation of the H2 site was not observed. Therefore, the high level of methylation observed for the HLB1-dimer transfectants was a direct result of the inserted B1 elements.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 3.   Southern blot analysis for EC cells transfected with the HLB1-6 and HLB1-dimer constructs. DNA preparations from transfectants were digested with HpaII and PstI and then Southern blot-hybridized with the N1 probe (Fig. 1A). A MspI digest lane is also shown for each construct. Fig. 1C contains a diagram showing the origin of each hybridization band.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Methylation levels for HpaII sites on transfected plasmids
The HL construct, inserts used to create methylation constructs, and the H1, H2, and H* sites are shown in Fig. 1.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 4.   Southern blot analysis for EC cells transfected with the HL272 construct. DNA preparations from transfectants were digested with HpaII and PstI and then Southern blot-hybridized with the N1 probe (Fig. 1A). A MspI digest lane is also shown.

To determine the relative contributions of the B1-5 and B1-6 elements to the de novo methylation signal, each element was inserted independently into the HL construct to create HLB1-5 and HLB1-6, respectively. Again, HpaII sites bracketed the fragments: an artificial 5' site for B1-5 and two artificial sites for B1-6. The B1-5 element was found to attract de novo methylation (Fig. 5) with average levels for the H1 and H2 sites of 60 and 11%, respectively (Table I). In contrast, methylation of the HLB1-6 construct occurred less frequently; only 2 of 6 transfectants displayed any methylation. The average levels of methylation was 16 and 5% for the 3' H* (i.e. equivalent location of the H1 site on B1-5) and the H2 sites, respectively. Therefore, the B1-5 and B1-6 elements are not functionally equivalent, with a far stronger activity being observed for the B1-5 element.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 5.   Southern blot analysis for EC cells transfected with the HLB1-5 and HLB1-5 (SDM) constructs. DNA preparations from transfectants were digested with HpaII and PstI and then Southern blot-hybridized with the N1 probe (Fig. 1A). A MspI digest lane is also shown for a HLB1-5 transfectant. Fig. 1C contains a diagram showing the origin of each hybridization band.

It has been proposed that clustering of CpG sites contributes to the methylation process (20-22). Although the B1-5 and B1-6 elements have relatively low densities of these sites, a small cluster of CpG sites is present at the 5' end of the B1-5 element (i.e. the 3' end of the methylation center). In this region 4 CpG dinucleotides are located within a stretch of 21 base pairs (Fig. 2B). To determine if this cluster is important for the ability of the B1-5 element to signal de novo methylation, all CpG dinucleotides except the one contained within the H1 site were eliminated by site-directed mutagenesis (C right-arrow T mutations) to create a construct termed HLB1-5SDM. Essentially no difference in methylation levels was observed when comparing the HLB1-5 and HLB1-5SDM constructs (Fig. 5, Table I), demonstrating that CpG density near the H1 site does not play an important role in its level of de novo methylation or for methylation spreading to the H2 site.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The endogenous targets for de novo DNA methylation in the mammalian genome have not been described (9). In previous work we identified a methylation center upstream of mouse Aprt that can signal de novo methylation when transfected into mouse EC cells and from which methylation can spread (10). We report here that two B1 repetitive elements are located at the 3' end of the methylation center and have used two approaches to obtain evidence suggesting strongly that this pair can act as a unit to create a strong de novo methylation signal.

The first approach was to examine methylation of CpG sites included within and flanking the B1-5 and B1-6 elements in ES cells homozygous for the Dnmtc/c allele. This allele contains a knockout mutation in the region of the Dnmt1 gene that encodes the catalytic domain. Therefore these cells lack the enzymatic function responsible for the spreading of methylation and its maintenance, although they still retain the capacity to methylate DNA de novo. Presumably the regions of the genome that remain methylated in these cells are those that attract most strongly de novo methylation. With the bisulfite-sequencing method we demonstrated that CpG sites in the B1 elements under study are methylated at a relative level of 43% in the Dnmtc/c cells when compared with the same sites in ES cells with wild type Dnmt1 alleles. If the above presumption is correct, these elements are acting as strong signals for de novo methylation. It is noted that the downstream H2 site, which becomes methylated as a function of spreading from the methylation center, is essentially unmethylated in the Dnmtc/c cells (9).

Methylation of other repetitive elements has also been reported in the Dnmtc/c ES cells. Using the bisulfite method, Woodcock et al. (23) show that CpG sites within A-repeats are methylated at a consensus relative level of 29% (absolute level of 13%) in the Dnmtc/c cells when compared with the wild type ES cells. A Southern blot analysis showed methylation of endogenous Moloney murine leukemia retrovirus in the Dnmtc/c cells, although the absolute and relative levels were not quantified (11). In contrast to these results, a very low level of methylation (<1.4%) was observed for CpG sites within the H19-imprinted region in the Dnmtc/c allele ES cells. This region is completely methylated on the marked alleles in the wild type ES cells (24).

The second approach we used to examine methylation potential for the B1 elements was to test their ability to become methylated de novo when transfected into mouse EC cells. These cells possess a high capacity for de novo methylation of transfected plasmid constructs that contain the methylation center (10, 14). Although some variability in methylation can be attributed to integration sites, the average methylation levels reflect sequence content of the transfected constructs (25). With this approach we found that the B1 dimer could direct a high level of methylation for the H1 and H2 sites, at average levels near that observed for the corresponding endogenous region (9, 17, 19). A similarly sized contiguous downstream fragment of 272 base pairs that lacked B1 elements failed to elicit a significant methylation response, which confirmed specificity for methylation of the B1 elements and which also confirmed that the H1 site is very close to the 3' end of the methylation center.

It is interesting to note that the human Alu repetitive element, which is homologous to the mouse B1 element, is found normally as a tandem pair of monomeric units (26). Copies of this element are methylated at high levels in human somatic cells (27, 28). Moreover, spreading of methylation from Alu elements has been suggested as playing a causal role in epigenetic inactivation of some tumor suppressor genes (29, 30). DNA fragments containing B1, B2, or L1 elements have been shown to enhance methylation of a bacterial chloramphenicol acetyltransferase fragment in F9 EC cells (31), although the elements were not tested as isolated units as performed here, and the chloramphenicol acetyltransferase fragment elicited significant methylation by itself. Moreover, the constructs were introduced by the calcium phosphate method, which can often lead to high copy numbers of integrated plasmids. High copy numbers can cause high levels of methylation (32). To prevent this form of nonspecific methylation, we used electroporation to keep copy numbers at low levels (14).

Although the B1-6 element did not become methylated when tested independently, suggesting that loss of the 5' end decreased its intrinsic methylation signal, an artificial HpaII site placed at its 3' end (i.e. 5' end of insert) became methylated at an average minimal level of 59% when combined in tandem with B1-5. Moreover, the CpG sites in B1-6 (two sites in P19 EC cells, one site in the ES cells) were methylated at high levels at their endogenous location in wild type cells (82% in ES cells) and at relatively high levels in the Dnmtc/c ES cells (27%). This latter observation is taken as evidence that these sites are methylated de novo at their endogenous location despite the relative lack of methylation of B1-6 when tested independently. In total, these data and those obtained with the B1-5 insert suggest that the B1-5 and B1-6 elements act synergistically in their normal tandem orientation to signal DNA methylation. The data obtained with the B1-5 insert further suggest that a single intact B1 element can provide a strong methylation signal. Considering that there are several hundred thousand B1 elements in the mouse genome (26), it is possible that B1 elements account for a significant fraction of mouse genome methylation.

Finally, the results obtained in this study have direct relevance for the hypothesis that a function of DNA methylation in mammalian cells is to protect the genome from expression and transposition of repetitive elements (1, 2). A large number of these elements exist in the mammalian genome, and in general they are highly methylated in somatic cells. As mentioned above, high levels of methylation have been observed for repetitive elements analyzed in Dnmtc/c cells. It has been suggested that methylation of repetitive elements can repress their expression, which is linked to transposition events, in two ways. One is by methylation-mediated transcriptional inactivation, and the second is by increasing the rates of C right-arrow T mutations over the course of evolution (2). An example of this type of mutation is the absence of CpG site 2 in B1-6 (Table I) in the 129/Sv strain. Our results provide the first direct demonstration that one class of repetitive elements, i.e. B1 elements derived from 7SL RNA, can signal methylation de novo. Similar findings with other endogenous "parasitic" elements are a logical prediction of the protection hypothesis and are necessary for its further testing.

    Acknowlegements

We thank En Li for providing the Dnmtc/c ES cells, Anita Piper for advice on bisulfite sequencing, and Tim Bestor for helpful comments.

    FOOTNOTES

* This work was supported by a grant from the Council for Tobacco Research (to M. S. T.) and National Institutes of Health predoctoral training Grant T32 (to R. W. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: CROET, L606, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd., Portland, OR 97201. Tel.: 503-494-2168; Fax: 503-494-3849; E-mail turkerm@ohsu.edu.

    ABBREVIATIONS

The abbreviations used are: EC, embryonal carcinoma; PCR, polymerase chain reaction.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Yoder, J. A., Walsh, C. P., and Bestor, T. H. (1997) Trends Genet. 13, 335-340[CrossRef][Medline] [Order article via Infotrieve]
2. Bestor, T. H. (1998) Novartis Found. Symp. 214, 187-195[Medline] [Order article via Infotrieve]
3. Sinnett, D., Richer, C., Deragon, J. M., and Labuda, D. (1991) J. Biol. Chem. 266, 8675-8678[Abstract/Free Full Text]
4. Labuda, D., Sinnett, D., Richer, C., Deragon, J. M., and Striker, G. (1991) J. Mol. Evol. 32, 405-414[CrossRef][Medline] [Order article via Infotrieve]
5. Liu, W. M., and Schmid, C. W. (1993) Nucleic Acids Res. 21, 1351-1359[Abstract/Free Full Text]
6. Liu, W. M., Maraia, R. J., Rubin, C. M., and Schmid, C. W. (1994) Nucleic Acids Res. 22, 1087-1095[Abstract/Free Full Text]
7. Walsh, C. P., Chaillet, J. R., and Bestor, T. H. (1998) Nat. Genet. 20, 116-117[CrossRef][Medline] [Order article via Infotrieve]
8. Jahner, D., and Jaenisch, R. (1985) Nature 315, 594-597[CrossRef][Medline] [Order article via Infotrieve]
9. Turker, M. S. (1999) Semin. Cancer Biol. 9, 329-337[CrossRef][Medline] [Order article via Infotrieve]
10. Mummaneni, P., Bishop, P. L., and Turker, M. S. (1993) J. Biol. Chem. 268, 552-558[Abstract/Free Full Text]
11. Lei, H., Oh, S. P., Okano, M., Jüttermann, R., Goss, K. A., Jaenisch, R., and Li, E. (1996) Development 122, 3195-3205[Abstract]
12. Turker, M., Walker, K. A., Jennings, C. D., Mellon, I., Yusufji, A., and Urano, M. (1995) Mutat. Res. 329, 97-105[CrossRef][Medline] [Order article via Infotrieve]
13. Turker, M. S., Stambrook, P. J., Tischfield, J. A., Smith, A. C., and Martin, G. M. (1989) Somatic Cell Mol. Genet. 15, 159-166[CrossRef][Medline] [Order article via Infotrieve]
14. Turker, M. S., Mummaneni, P., and Bishop, P. L. (1991) Somatic Cell Mol. Genet. 17, 151-157[CrossRef][Medline] [Order article via Infotrieve]
15. McDonald, L. E., and Kay, G. F. (1997) Biotechniques 22, 272-274[Medline] [Order article via Infotrieve]
16. Paulin, R., Grigg, G. W., Davey, M. W., and Piper, A. A. (1998) Nucleic Acids Res. 26, 5009-5010[Abstract/Free Full Text]
17. Turker, M. S., Swisshelm, K., Smith, A. C., and Martin, G. M. (1989) J. Biol. Chem. 264, 11632-11636[Abstract/Free Full Text]
18. Quentin, Y. (1994) Nucleic Acids Res. 25, 2222-2227
19. Turker, M. S., Mummaneni, P., and Cooper, G. E. (1994) Adv. Exp. Med. Biol. 111, 647-652
20. Bolden, A. H., Nalin, C. M., Ward, C. A., Poonian, M. S., McComas, W. W., and Weissbach, A. (1985) Nucleic Acids Res. 13, 3479-3494[Abstract/Free Full Text]
21. Bolden, A. H., Nalin, C. M., Ward, C. A., Poonian, M. S., and Weissbach, A. (1986) Mol. Cell. Biol. 6, 1135-1140[Abstract/Free Full Text]
22. Ward, C., Bolden, A., Nalin, C. M., and Weissbach, A. (1987) J. Biol. Chem. 262, 11057-11063[Abstract/Free Full Text]
23. Woodcock, D. M., Linsenmeyer, M. E., and Warren, W. D. (1998) Gene 206, 63-67[CrossRef][Medline] [Order article via Infotrieve]
24. Warnecke, P. M., Biniszkiewicz, D., Jaenisch, R., Frommer, M., and Clark, S. J. (1998) Dev. Genet. 22, 111-121[CrossRef][Medline] [Order article via Infotrieve]
25. Hertz, J. M., Schell, G., and Doerfler, W. (1999) J. Biol. Chem. 274, 24232-24240[Abstract/Free Full Text]
26. Schmid, C. W., and Jelinek, W. R. (1982) Science 216, 1065-1070[Abstract/Free Full Text]
27. Hellmann-Blumberg, U., Hintz, M. F., Gatewood, J. M., and Schmid, C. W. (1993) Mol. Cell. Biol. 13, 4523-4530[Abstract/Free Full Text]
28. Kochanek, S., Renz, D., and Doerfler, W. (1993) EMBO J. 12, 1141-1151[Medline] [Order article via Infotrieve]
29. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J.-P. (1998) Adv. Cancer Res. 72, 141-196[Medline] [Order article via Infotrieve]
30. Graff, J. R., Herman, J. G., Myöhänen, S., Baylin, S. B., and Vertino, P. M. (1997) J. Biol. Chem. 272, 22322-22329[Abstract/Free Full Text]
31. Hasse, A., and Schultz, W. A. (1994) J. Biol. Chem. 269, 1821-1826[Abstract/Free Full Text]
32. Garrick, D., Fiering, S., Martin, D. I. K., and Whitelaw, E. (1998) Nat. Genet. 18, 56-59[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Genes Dev.Home page
H. R. Woo and E. J. Richards
Signaling silence--breaking ground and spreading out
Genes & Dev., July 1, 2008; 22(13): 1719 - 1723.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Strathdee, C. B. A. Whitelaw, and A. J. Clark
Distal Transgene Insertion Affects CpG Island Maintenance during Differentiation
J. Biol. Chem., April 25, 2008; 283(17): 11509 - 11515.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
H.-R. Wang, C.-Y. Hsieh, Y.-C. Twu, and L.-C. Yu
Expression of the Human Sda -1,4-N-Acetylgalactosaminyltransferase II Gene is Dependent on the Promoter Methylation Status
Glycobiology, January 1, 2008; 18(1): 104 - 113.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. J. Wood, D. Bourc'his, T. H. Bestor, and R. J. Oakey
Allele-specific demethylation at an imprinted mammalian promoter
Nucleic Acids Res., November 29, 2007; 35(20): 7031 - 7039.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
W. M Grady
CIMP and colon cancer gets more complicated
Gut, November 1, 2007; 56(11): 1498 - 1500.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Meunier, A. Khelifi, V. Navratil, and L. Duret
Homology-dependent methylation in primate repetitive DNA
PNAS, April 12, 2005; 102(15): 5471 - 5476.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. Kim, Y. M. Kwon, J. S. Kim, H. Lee, J.-H. Park, Y. M. Shim, J. Han, J. Park, and D.-H. Kim
Tumor-Specific Methylation in Bronchial Lavage for the Early Detection of Non-Small-Cell Lung Cancer
J. Clin. Oncol., June 15, 2004; 22(12): 2363 - 2370.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. A. Feltus, E. K. Lee, J. F. Costello, C. Plass, and P. M. Vertino
Predicting aberrant CpG island methylation
PNAS, October 14, 2003; 100(21): 12253 - 12258.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. N. Carnell and J. I. Goodman
The Long (LINEs) and the Short (SINEs) of It: Altered Methylation as a Precursor to Toxicity
Toxicol. Sci., October 1, 2003; 75(2): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Coombes, P. Arnaud, E. Gordon, W. Dean, E. A. Coar, C. M. Williamson, R. Feil, J. Peters, and G. Kelsey
Epigenetic Properties and Identification of an Imprint Mark in the Nesp-Gnasxl Domain of the Mouse Gnas Imprinted Locus
Mol. Cell. Biol., August 15, 2003; 23(16): 5475 - 5488.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. A. Yates, R. Burman, J. Simpson, O. N. Ponomoreva, M. J. Thayer, and M. S. Turker
Silencing of Mouse Aprt Is a Gradual Process in Differentiated Cells
Mol. Cell. Biol., July 1, 2003; 23(13): 4461 - 4470.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Tamaru and E. U. Selker
Synthesis of Signals for De Novo DNA Methylation in Neurospora crassa
Mol. Cell. Biol., April 1, 2003; 23(7): 2379 - 2394.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
N. C. Riddle and E. J. Richards
The Control of Natural Variation in Cytosine Methylation in Arabidopsis
Genetics, September 1, 2002; 162(1): 355 - 363.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Reinhart, M. Eljanne, and J. R. Chaillet
Shared Role for Differentially Methylated Domains of Imprinted Genes
Mol. Cell. Biol., April 1, 2002; 22(7): 2089 - 2098.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. G. Lin, L. Han, A. Taghva, L. E. O'Brien, and C.-L. Hsieh
Murine De Novo Methyltransferase Dnmt3a Demonstrates Strand Asymmetry and Site Preference in the Methylation of DNA In Vitro
Mol. Cell. Biol., February 1, 2002; 22(3): 704 - 723.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Bird
DNA methylation patterns and epigenetic memory
Genes & Dev., January 1, 2002; 16(1): 6 - 21.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Greally
Short interspersed transposable elements (SINEs) are excluded from imprinted regions in the human genome
PNAS, December 21, 2001; (2001) 12539199.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Singal and J. M. vanWert
De novo methylation of an embryonic globin gene during normal development is strand specific and spreads from the proximal transcribed region
Blood, December 1, 2001; 98(12): 3441 - 3446.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. C. Rice and B. W. Futscher
Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter
Nucleic Acids Res., September 1, 2000; 28(17): 3233 - 3239.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Arnaud, C. Goubely, T. Pélissier, and J.-M. Deragon
SINE Retroposons Can Be Used In Vivo as Nucleation Centers for De Novo Methylation
Mol. Cell. Biol., May 15, 2000; 20(10): 3434 - 3441.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Greally
Short interspersed transposable elements (SINEs) are excluded from imprinted regions in the human genome
PNAS, January 8, 2002; 99(1): 327 - 332.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract